Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Neoplasm Metastasis 7 Lung Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Ovarian Neoplasms 5 Melanoma 5 Carcinoma, Renal Cell 5 Skin Neoplasms 4 Fallopian Tube Neoplasms 4 Carcinoma 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Prostatic Neoplasms 3 Mouth Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Laryngeal Neoplasms 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Colonic Neoplasms 2

Interventions

Drug Therapy 4 Pemetrexed 3 Carboplatin 3 osimertinib 2 Radiotherapy 2 toripalimab 1 tislelizumab 1 sugemalimab 1 spartalizumab 1 sintilimab 1 pembrolizumab 1 cemiplimab 1 aflutinib 1 Vinorelbine 1 Radiosurgery 1 Platinum 1 Paclitaxel 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NSCLC × cemiplimab × Clear all

NCT06865339 2026-04-13

TRIPL

Montefiore Medical Center

Phase 2 Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡